Characterizing the Role of Brain Derived Neurotrophic Factor Genetic Variation in Alzheimer’s Disease Neurodegeneration

• Robyn A. Honea ,

  * E-mail: rhonea@kumc.edu

  Affiliation Department of Neurology, University of Kansas Alzheimer’s Disease Center, University of Kansas Medical Center, Kansas City, Kansas, United States of America

  ⨯
• Carlos Cruchaga,

  Affiliation Department of Psychiatry & Neurology, Washington University School of Medicine, St. Louis, Missouri, United States of America

  ⨯
• Rodrigo D. Perea,

  Affiliation Department of Neurology, University of Kansas Alzheimer’s Disease Center, University of Kansas Medical Center, Kansas City, Kansas, United States of America

  ⨯
• Andrew J. Saykin,

  Affiliations Center for Neuroimaging, Division of Imaging Sciences, Department of Radiology, Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, Indiana, United States of America, Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, United States of America

  ⨯
• Jeffrey M. Burns,

  Affiliation Department of Neurology, University of Kansas Alzheimer’s Disease Center, University of Kansas Medical Center, Kansas City, Kansas, United States of America

  ⨯
• Daniel R. Weinberger,

  Affiliations Lieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, Maryland, United States of America, Departments of Psychiatry, Neurology, Neuroscience and the McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Alison M. Goate,

  Affiliation Department of Psychiatry & Neurology, Washington University School of Medicine, St. Louis, Missouri, United States of America

  ⨯
• For the Alzheimer’s Disease Neuroimaging Initiative (ADNI)